Precursor Igf-II (proIGF-II) and mature IGF-II (mIGF-II) induce Bcl-2 and Bcl-XL expression through different signaling pathways in breast cancer cells

Growth Factors

Volumn 26, Issue 2, 2008, Pages 92-103

  Singh, S Kalla ^a   Moretta, D ^a   Almaguel, F ^a   De Leon M ^a   De León, Daisy D ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Akt; Bcl 2; Bcl XL; CREB; Insulin like growth factor II; MCF 7

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE B; RESVERATROL; SOMATOMEDIN B; SOMATOMEDIN C RECEPTOR;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER RESISTANCE; CELL STRAIN MCF 7; CELL TRANSPORT; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HYPOTHESIS; MEMBRANE DEPOLARIZATION; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BCL-X PROTEIN; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; CYTOCHROMES C; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INSULIN-LIKE GROWTH FACTOR II; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MITOCHONDRIAL MEMBRANES; PHOSPHORYLATION; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STILBENES;

RICE STRIPE VIRUS;

EID: 42549167185     PISSN: 08977194     EISSN: 10292292     Source Type: Journal    
DOI: 10.1080/08977190802057258     Document Type: Article

References (31)

1. Benz, CC (2004) HER2 and endocrine response in breast cancer: The evidence for clinical application of estrogen receptor status. Oncol Exchange, 3:21, pp. 8-11.
2. Catz, SD and Johnson, JL (2001) Transcriptional regulation of Bcl-2 by NF-KB and its significance in prostate cancer. Oncogene, 20:50, pp. 7342-7351.
3. Dearth, RK, Cui, X., Kim, H-J, Hadsell, DL and Lee, AV (2007) Oncogenic transformation by the signaling adaptor proteins insulin receptor substrate (IRS)-1 and IRS-2. Cell Cycle, 6:6, pp. 705-713.
4. De León, DD, Wilson, DM, Powers, M. and Rosenfeld, RG (1992) Effects of IGFs and IGF receptor antibodies on the proliferation of breast cancer cells. Growth Factors, 6:4, pp. 327-336.
5. España, L., Martín, B., Aragués, R., Chiva, C., Oliva, B., Andreu, D. and Sierra, A. (2005) Bcl-XL-mediated changes in metabolic pathways of breast cancer cells: From survival in the blood stream to organ-specific metastasis. Am J Pathol, 167:4, pp. 1125-1137.
6. Fiebig, AA, Zhu, W., Hollerbach, C., Leber, B. and Andrews, DW (2006) Bcl-XL is qualitatively different and ten times more effective than Bcl-2 when expressed in a breast cancer cell line. BMC Cancer, 6:213
7. Gibson, SL, Ma, Z. and Shaw, LM (2007) Divergent roles for IRS-1 and IRS-2 in breast cancer metastasis. Cell Cycle, 6:6, pp. 631-637.
8. González-García, M., Pérez-Ballestero, R., Ding, L., Duan, L., Boise, LH, Thompson, CB and Nuñez, G. (1994) Bcl-XL is the major Bcl-X mRNA form expressed during murine development and its product localizes to mitochondria. Development, 120, pp. 3033-3042.
9. Hansen, BF, Danielsen, GM, Drejer, K., Sørensen, AR, Wiberg, FC, Klein, HH and Lundemose, AG (1996) Sustained signaling from the insulin receptor after stimulation with insulin analogues exhibiting increased mitogenic potency. Biochem J, 315, pp. 271-279.
10. Heffelfinger, SC, Miller, MA, Yassin, R. and Gear, R. (1999) Angiogenic growth factors in preinvasive breast disease. Clin Cancer Res, 5, pp. 2867-2876.
11. Hers, I., Bell, CJ, Poole, AW, Jiang, D., Denton, RM and Schaefer, E. (2002) Reciprocal feedback regulation of insulin receptor and insulin substrate tyrosine phosphorylation by PI3K in primary adipocytes. Biochem J, 368, pp. 875-884.
12. Hirano, S., Furutama, D. and Hanafusa, T. (2006) Physiologically high concentrations of 17-B estradiol enhance NF-KB activity in human T cells. Am J Physiol Regul Integr Comp Physiol, 292, pp. 465-471.
13. Singh, S Kalla, Moretta, D., Almaguel, F., Wall, NR, De Léon, M. and De Léon, D. (2008) Differential effect of proIGF-II and mIGF-II on resveratrol induced cell death by regulating survivin cellular localization and mitochondrial depolarization in breast cancer cells. Growth Factors, 25:6, pp. 363-372.
14. Kim, EJ, Holthuizen, PE, Kim, J. and Park, JH (2005) Overexpression of mature IGF-II leads to growth arrest in Caco-2 human colon cancer cells. Growth Horm IGF Res, 15:1, pp. 64-71.
15. Korn, E., Van Hoff, J., Buckley, P., Daughaday, WH and Carpenter, TO (1995) Secretion of a large molecular-weight form of insulin-like growth factor by a primary renal tumor. Med Pediatr Oncol, 24:6, pp. 392-396.
16. Lee, AV, Darbre, P. and King, RJ (1994) Processing of IGF-II by human breast cancer cells. Mol Cell Endocrinol, 99:2, pp. 211-220.
17. Lee, HH, Dadgostar, H., Cheng, Q., Shu, J. and Cheng, G. (1999) NF-KB mediated up-regulation of Bcl-X and Bfl-1/A1 is required for CD40survival signaling in B lymphocytes. Proc Natl Acad Sci USA, 96:16, pp. 9136-9141.
18. Lipponen, P., Pietilainen, T., Kosma, VM, Aaltomaa, S., Eskelinen, M. and Syrjanen, KJ (1995) Apoptosis suppressing protein Bcl-2 is expressed in well differentiated breast carcinomas with favourable prognosis. J Pathol, 177, pp. 49-55.
19. Liu, W., Liu, Y. and Lowe, WL (2001) The role of PI3K and MAPK in IGF-I mediated effects in vascular endothelial cells. Endocrinology, 142:5, pp. 1710-1719.
20. Méndez, O., Martín, B., Sanz, R., Aragüés, R., Moreno, V., Oliva, B., Stresing, V. and Sierra, A. (2006) Underexpression of transcriptional regulators is common in metastatic breast cancer cells overexpressing Bcl-XL. Carcinogenesis, 27:6, pp. 1169-1179.
21. Myers, MG, Mendez, R., Shi, P., Pierce, JH, Rhoads, R. and White, MF (1998) The COOH-terminal tyrosine phosphorylation sites on IRS-1 bind SHP-2 and negatively regulates insulin signaling. J Biol Chem, 273:41, pp. 26908-26914.
22. Olopade, OI, Adeyanju, MO, Safa, AR, Hagos, F., Mick, R., Thompson, CB and Recant, WM (1997) Overexpression of Bcl-X protein in primary breast cancer is associated with high tumor grade and nodal metastases. Cancer J Sci Am, 3:4, pp. 230-237.
23. Rossé, T., Olivier, R., Monney, L., Rager, M., Conus, S., Fellay, I., Jansen, B. and Borner, C. (1998) Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c. Nature, 391, pp. 496-499.
24. Sciacca, L., Mineo, R., Pandini, G., Murabito, A., Vigneri, R. and Belfiore, A. (2002) In IGF-I receptor deficient leiomyosarcoma cells autocrine IGF-II induces cell invasion and protection from apoptosis via the insulin receptor isoform A. Oncogene, 21:54, pp. 8240-8250.
25. Shaywitz, AJ and Greenberg, ME (1999) CREB: A stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu Rev Biochem, 68, pp. 821-861.
26. Tsuruta, F., Masuyama, N. and Gotoh, Y. (2002) The PI3K-Akt pathway suppresses Bax translocation to mitochondria. J Biol Chem, 277:16, pp. 14040-14047.
27. Vyas, S., Asmerom, Y. and DeLeon, DD (2005) Resveratrol regulates IGF-II in breast cancer cells. Endocrinology, 146:10, pp. 4224-4233.
28. Yang, CQ, Zhan, X., Hu, X., Kondepudi, A. and Perdue, JF (1996) The expression and characterization of recombinant proIGF-IIand a mutant that is defective in the O-glycosylation of its E-domain. Endocrinology, 137:7, pp. 2766-2773.
29. Yee, D. and Lee, AV (2000) Crosstalk between the IGFs and estrogens in breast cancer. J Mammary Gland Biol Neoplasia, 5, pp. 107-115.
30. Zimmermann, S. and Moelling, K. (1999) Phosphorylation and regulation of Raf by Akt. Science, 286, pp. 1741-1744.
31. Zhou, Y., Eppenberger-Castori, S., Eppenberger, U. and Benz, CC (2005) The NF-KB and endocrine-resistant breast cancer. Endocr Relat Cancer, 12, pp. S37-S46.